Related Experiment Video
Updated: Aug 11, 2026
11:36
Cutaneous Leishmaniasis in the Dorsal Skin of Hamsters: a Useful Model for the Screening of Antileishmanial Drugs
Published on: April 21, 2012
New developments in the chemotherapy of leishmaniasis
1Liverpool School of Tropical Medicine, U.K.
Annals of Tropical Medicine and Parasitology
|December 1, 1995
Summary
Recent advances in leishmaniasis chemotherapy include improved drug pharmacokinetics, novel agents like aminosidine, and effective lipid-associated amphotericin B treatments. Combination therapies and immune modulators also show promise for treating this parasitic disease.
Area of Science:
- Infectious Diseases
- Pharmacology
- Parasitology
Background:
- Leishmaniasis chemotherapy has seen significant progress over the past decade.
- Understanding drug pharmacokinetics is crucial for effective treatment strategies.
Purpose of the Study:
- To review recent advances in the chemotherapy of leishmaniasis.
- To highlight novel therapeutic approaches and drug development in leishmaniasis treatment.
Main Methods:
- Review of recent scientific literature on leishmaniasis chemotherapy.
- Analysis of pharmacokinetic data for key antileishmanial drugs.
- Evaluation of new drug introductions and combination therapy strategies.
Main Results:
- Improved understanding of pentavalent antimonials' pharmacokinetics.
- Introduction of aminosidine for systemic and topical treatment of cutaneous leishmaniasis.
- High efficacy of short-course treatments with lipid-associated amphotericin B.
- Demonstrated utility of combination therapy and immunomodulators.
- Exploitation of distinct Leishmania biochemical pathways (purine, sterol metabolism) for drug targeting.
Conclusions:
- Recent advances have significantly improved leishmaniasis treatment options.
- Novel drugs, optimized drug delivery, and combination therapies represent key progress.
- Targeting unique parasite biochemical pathways offers a rational approach to developing new antileishmanial agents.
More Related Videos
12:22A Parasite Rescue and Transformation Assay for Antileishmanial Screening Against Intracellular Leishmania donovani Amastigotes in THP1 Human Acute Monocytic Leukemia Cell Line
Published on: December 30, 2012
10:03Development of Leishmania Species Strains with Constitutive Expression of eGFP
Published on: April 21, 2023
Related Concept Videos
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:30Leishmaniasis
Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
01:15Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...